The Invisible Cancer: Understanding Neuroendocrine Tumors

A rare and often misdiagnosed cancer, neuroendocrine tumors (NETs) are gaining recognition as medical understanding improves. These slow-growing cancers, arising from hormone-producing cells, can be difficult to detect due to their vague and often overlapping symptoms. This article explores the challenges of diagnosing NETs, the experiences of patients like Kerie Ivory and the growing awareness surrounding this “invisible” cancer.

What are Neuroendocrine Tumors?

Neuroendocrine tumors develop from specialized cells that produce hormones. These cells are found throughout the body, meaning NETs can occur in various locations, including the lungs, pancreas, stomach, and intestines. According to the Neuroendocrine Cancer Foundation in the United Kingdom, approximately 6,000 people in England are diagnosed with neuroendocrine cancer each year.

The Challenges of Diagnosis

One of the biggest hurdles in managing NETs is the difficulty in obtaining a timely diagnosis. Symptoms are often non-specific and can mimic more common conditions like irritable bowel syndrome, asthma, or even menopause. This can lead to delays in treatment and a frustrating experience for patients.

Kerie Ivory, a 52-year-old woman from Buckinghamshire, experienced this firsthand. Her initial symptoms – a persistent cough, acid reflux, and fatigue – were dismissed for 15 months before she received a diagnosis of little bowel neuroendocrine cancer that had spread to other parts of her body. She described the process as “incredibly frustrating and humiliating to be ignored for so long.”

The incidence of neuroendocrine cancers has been rising. Between 1995 and 2018, the incidence in England increased by 371%, compared to an overall cancer incidence increase of 116% (excluding non-melanoma skin cancer).

Symptoms of Neuroendocrine Tumors

Symptoms of NETs can vary depending on the location of the tumor and the hormones it produces. Common symptoms include:

• Unexplained weight loss
• Extreme fatigue
• Diarrhea
• Bloating
• Acidity
• Skin rashes
• Chronic cough

Treatment and Outlook

Treatment options for NETs depend on the stage and location of the cancer. Surgery, chemotherapy, and targeted therapies may be used. Yet, for some patients, like Kerie Ivory, conventional treatments are not always effective, particularly with slow-growing tumors. This can leave patients in a difficult position, waiting for tumors to grow large enough to warrant treatment.

Raising Awareness

Kerie Ivory is now participating in awareness campaigns, hoping to share her story and improve early diagnosis for others. The introduction of “Jess’s Rule” – encouraging doctors to reassess patients with unresolved symptoms after multiple visits – is a positive step towards improving diagnosis.

Key Takeaways

• Neuroendocrine tumors are rare cancers that can be difficult to diagnose.
• Symptoms are often vague and mimic other common conditions.
• Early diagnosis is crucial for effective treatment.
• Increased awareness and initiatives like Jess’s Rule are helping to improve diagnosis rates.